117 related articles for article (PubMed ID: 31420708)
1. [The risk of subsequent primary cancer after radiotherapy of localised prostate cancer with carbon ions may be reduced compared to treatment with photons].
Kraus KM; Combs SE
Strahlenther Onkol; 2019 Nov; 195(11):1033-1035. PubMed ID: 31420708
[No Abstract] [Full Text] [Related]
2. Risk of subsequent primary cancers after carbon ion radiotherapy, photon radiotherapy, or surgery for localised prostate cancer: a propensity score-weighted, retrospective, cohort study.
Mohamad O; Tabuchi T; Nitta Y; Nomoto A; Sato A; Kasuya G; Makishima H; Choy H; Yamada S; Morishima T; Tsuji H; Miyashiro I; Kamada T
Lancet Oncol; 2019 May; 20(5):674-685. PubMed ID: 30885458
[TBL] [Abstract][Full Text] [Related]
3. Should we expand the carbon ion footprint of prostate cancer?
Catton CN; Shultz DB
Lancet Oncol; 2019 May; 20(5):608-609. PubMed ID: 30885459
[No Abstract] [Full Text] [Related]
4. Carbon ion radiotherapy: impact of tumor differentiation on local control in experimental prostate carcinomas.
Glowa C; Peschke P; Brons S; Neels OC; Kopka K; Debus J; Karger CP
Radiat Oncol; 2017 Nov; 12(1):174. PubMed ID: 29121984
[TBL] [Abstract][Full Text] [Related]
5. Intrinsic and extrinsic tumor characteristics are of minor relevance for the efficacy of split-dose carbon ion irradiation in three experimental prostate tumors.
Glowa C; Peschke P; Brons S; Debus J; Karger CP
Radiother Oncol; 2019 Apr; 133():120-124. PubMed ID: 30935567
[TBL] [Abstract][Full Text] [Related]
6. Key considerations when reviewing subsequent primary cancers following radiotherapy.
Kishan AU; Wang C; Steinberg ML; Spratt DE
Lancet Oncol; 2019 Jun; 20(6):e291. PubMed ID: 31162098
[No Abstract] [Full Text] [Related]
7. Key considerations when reviewing subsequent primary cancers following radiotherapy - Authors' reply.
Mohamad O; Tabuchi T; Morishima T; Makishima H; Miyashiro I; Tsuji H
Lancet Oncol; 2019 Jun; 20(6):e292. PubMed ID: 31162099
[No Abstract] [Full Text] [Related]
8. Phase II multi-institutional clinical trial on a new mixed beam RT scheme of IMRT on pelvis combined with a carbon ion boost for high-risk prostate cancer patients.
Marvaso G; Jereczek-Fossa BA; Vischioni B; Ciardo D; Giandini T; Hasegawa A; Cattani F; Carrara M; Ciocca M; Bedini N; Villa S; Morlino S; Russo S; Zerini D; Colangione SP; Panaino CMV; Fodor C; Santoro L; Pignoli E; Valvo F; Valdagni R; De Cobelli O; Orecchia R
Tumori; 2017 May; 103(3):314-318. PubMed ID: 28009421
[TBL] [Abstract][Full Text] [Related]
9. Impact of Single Dose Photons and Carbon Ions on Perfusion and Vascular Permeability: A Dynamic Contrast-Enhanced MRI Pilot Study in the Anaplastic Rat Prostate Tumor R3327-AT1.
Bendinger AL; Seyler L; Saager M; Debus C; Peschke P; Komljenovic D; Debus J; Peter J; Floca RO; Karger CP; Glowa C
Radiat Res; 2020 Jan; 193(1):34-45. PubMed ID: 31697210
[TBL] [Abstract][Full Text] [Related]
10. Photon and carbon ion irradiation of a rat prostate carcinoma: does a higher fraction number increase the metastatic rate?
Karger CP; Scholz M; Huber PE; Debus J; Peschke P
Radiat Res; 2014 Jun; 181(6):623-8. PubMed ID: 24844648
[TBL] [Abstract][Full Text] [Related]
11. Relative biological effectiveness of carbon ions in a rat prostate carcinoma in vivo: comparison of 1, 2, and 6 fractions.
Karger CP; Peschke P; Scholz M; Huber PE; Debus J
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):450-5. PubMed ID: 23474116
[TBL] [Abstract][Full Text] [Related]
12. DNA damage response of clinical carbon ion versus photon radiation in human glioblastoma cells.
Lopez Perez R; Nicolay NH; Wolf JC; Frister M; Schmezer P; Weber KJ; Huber PE
Radiother Oncol; 2019 Apr; 133():77-86. PubMed ID: 30935585
[TBL] [Abstract][Full Text] [Related]
13. A validated tumor control probability model based on a meta-analysis of low, intermediate, and high-risk prostate cancer patients treated by photon, proton, or carbon-ion radiotherapy.
Walsh S; Roelofs E; Kuess P; Lambin P; Jones B; Georg D; Verhaegen F
Med Phys; 2016 Feb; 43(2):734-47. PubMed ID: 26843237
[TBL] [Abstract][Full Text] [Related]
14. Differential pattern of HIF-1α expression in HNSCC cancer stem cells after carbon ion or photon irradiation: one molecular explanation of the oxygen effect.
Wozny AS; Lauret A; Battiston-Montagne P; Guy JB; Beuve M; Cunha M; Saintigny Y; Blond E; Magne N; Lalle P; Ardail D; Alphonse G; Rodriguez-Lafrasse C
Br J Cancer; 2017 May; 116(10):1340-1349. PubMed ID: 28407653
[TBL] [Abstract][Full Text] [Related]
15. [Heavy ion radiotherapy for prostate cancer -- the role of hormone therapy].
Suzuki K; Matsui H; Kawamura H; Ohno T
Gan To Kagaku Ryoho; 2015 Feb; 42(2):159-63. PubMed ID: 25743135
[TBL] [Abstract][Full Text] [Related]
16. Overview of clinical experiences on carbon ion radiotherapy at NIRS.
Tsujii H; Mizoe JE; Kamada T; Baba M; Kato S; Kato H; Tsuji H; Yamada S; Yasuda S; Ohno T; Yanagi T; Hasegawa A; Sugawara T; Ezawa H; Kandatsu S; Yoshikawa K; Kishimoto R; Miyamoto T
Radiother Oncol; 2004 Dec; 73 Suppl 2():S41-9. PubMed ID: 15971308
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.
Georg D; Hopfgartner J; Gòra J; Kuess P; Kragl G; Berger D; Hegazy N; Goldner G; Georg P
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):715-22. PubMed ID: 24521685
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of J-CAPRA score for high-risk prostate cancer patients treated with carbon ion radiotherapy plus androgen deprivation therapy.
Akakura K; Tsuji H; Suzuki H; Ichikawa T; Ishikawa H; Okada T; Kamada T; Harada M; Tsujii H; Shimazaki J
Jpn J Clin Oncol; 2014 Apr; 44(4):360-5. PubMed ID: 24585931
[TBL] [Abstract][Full Text] [Related]
19. Oncogene addiction and radiation oncology: effect of radiotherapy with photons and carbon ions in ALK-EML4 translocated NSCLC.
Dai Y; Wei Q; Schwager C; Hanne J; Zhou C; Herfarth K; Rieken S; Lipson KE; Debus J; Abdollahi A
Radiat Oncol; 2018 Jan; 13(1):1. PubMed ID: 29304828
[TBL] [Abstract][Full Text] [Related]
20. Comparison of carbon ion radiotherapy to photon radiation alone or in combination with temozolomide in patients with high-grade gliomas: explorative hypothesis-generating retrospective analysis.
Combs SE; Bruckner T; Mizoe JE; Kamada T; Tsujii H; Kieser M; Debus J
Radiother Oncol; 2013 Jul; 108(1):132-5. PubMed ID: 23932193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
